Stopa Edward G, Butala Parag, Salloway Stephen, Johanson Conrad E, Gonzalez Liliana, Tavares Rosemarie, Hovanesian Virginia, Hulette Christine M, Vitek Michael P, Cohen Ronald A
Department of Pathology, Brown University School of Medicine, Providence, RI 02903, USA.
Stroke. 2008 Mar;39(3):814-21. doi: 10.1161/STROKEAHA.107.493429. Epub 2008 Feb 7.
We examined the associations among the vascular beta-amyloid levels, smooth muscle actin, wall thickness, and lumen diameter to achieve greater understanding of the arteriolar changes that accompany Alzheimer disease (AD).
Post-mortem pathology brain specimens from 76 patients with AD and 19 non-AD age control subjects were studied. We analyzed arterioles of the frontal cortex (Brodmann area 10) by immunohistochemistry and morphometry, and derived measures of vascular beta-amyloid level, smooth muscle actin (SMA) volume, and arteriolar wall thickness and lumen diameter. APOE genotype was determined for each case.
Overall, there was a striking reciprocal relationship between arteriolar beta-amyloid volume and smooth muscle actin (P<0.0001). In addition, there was a strong positive association between progressively accumulating vascular beta-amyloid and augmentations in both wall thickness (P<0.0001) and lumen width (P<0.0001). In comparison with non-AD control subjects, smooth muscle actin was decreased in patients clinically diagnosed with AD and was reduced >10-fold in cases with AD pathology (Braak I to VI) compared with those lacking AD neuropathology. Significantly altered composition and structure of cortical vessels in pre-Braak stages corroborated our hypothesis that arterioles are devastated early in the AD pathological process. Smooth muscle actin, arteriolar wall thickness, and luminal diameter did not vary with Braak stage severity (P>0.05), indicating that substantial arteriolar damage may precede at least some of the interstitial plaques and neuronal tangles. Moreover, the structural and biochemical arteriolar abnormalities did not vary as a function of APOE genotype (P>0.05).
We postulate that in elderly patients, the continually progressing beta-amyloid-associated angiopathy, at the arteriolar level, harms the contractile apparatus and cerebral blood flow autoregulation, thereby making the downstream capillaries vulnerable to damage. Collectively, our observations lend further support to the idea that microvascular damage has a role, perhaps relatively early, in the onset of major AD pathology.
我们研究了血管β淀粉样蛋白水平、平滑肌肌动蛋白、血管壁厚度和管腔直径之间的关系,以更深入地了解阿尔茨海默病(AD)伴随的小动脉变化。
研究了76例AD患者和19例非AD年龄匹配对照受试者的死后病理脑标本。我们通过免疫组织化学和形态计量学分析额叶皮质(布罗德曼区10)的小动脉,并得出血管β淀粉样蛋白水平、平滑肌肌动蛋白(SMA)体积以及小动脉壁厚度和管腔直径的测量值。确定了每个病例的APOE基因型。
总体而言,小动脉β淀粉样蛋白体积与平滑肌肌动蛋白之间存在显著的反比关系(P<0.0001)。此外,逐渐积累的血管β淀粉样蛋白与血管壁厚度(P<0.0001)和管腔宽度(P<0.0001)的增加之间存在强烈的正相关。与非AD对照受试者相比,临床诊断为AD的患者平滑肌肌动蛋白减少,与缺乏AD神经病理学的患者相比,有AD病理(Braak I至VI)的患者平滑肌肌动蛋白减少超过10倍。Braak前期皮质血管的组成和结构发生显著改变,证实了我们的假设,即小动脉在AD病理过程早期就受到破坏。平滑肌肌动蛋白、小动脉壁厚度和管腔直径不随Braak分期严重程度而变化(P>0.05),表明至少在一些间质斑块和神经元缠结之前可能就存在实质性的小动脉损伤。此外,小动脉的结构和生化异常不随APOE基因型而变化(P>0.05)。
我们推测,在老年患者中,小动脉水平上不断进展的β淀粉样蛋白相关血管病变会损害收缩装置和脑血流自动调节,从而使下游毛细血管易受损伤。总体而言,我们的观察结果进一步支持了微血管损伤在主要AD病理发生中可能起作用(可能相对较早)的观点。